Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis

K. Zycinska, M. Romanowska, I. Nowak, K. Wardyn, L. Brydak (Warsaw, Poland)

Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Session: Clinical aspects of inflammatory airways diseases
Session type: Thematic Poster Session
Number: 2165
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Zycinska, M. Romanowska, I. Nowak, K. Wardyn, L. Brydak (Warsaw, Poland). Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis. Eur Respir J 2009; 34: Suppl. 53, 2165

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Influenza vaccine-induced interstitial lung disease
Source: Eur Respir J 2013; 41: 474-477
Year: 2013


Influenza vaccine-induced ILD
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Goodpasture syndrome after H1N1 influenza pneumonia
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019

Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008



Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008

Immunity to pneumococcal disease
Source: Annual Congress 2013 –New understanding of pneumococcal vaccination
Year: 2013


Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019


Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

The humoral immune response to influenza vaccination in lung transplant patients
Source: Eur Respir J 2001; 18: 971-976
Year: 2001



Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011